SZLS.TSX
StageZero Life Sciences Ltd

424
Mkt Cap
$630,100.00
Volume
1,075.00
52W High
$0.0727
52W Low
$0.0005
Price
$0.0051
SZLS.TSX Fundamentals
Prev Close
$0.0005
Open
$0.0051
50D MA
$0.0012
Beta
2.25
Avg. Volume
48.86
Loading...
Loading...

About

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A

Frequently Asked Questions

What is Market Cap of StageZero Life Sciences Ltd?
What is the 52-week high for StageZero Life Sciences Ltd?
What is the 52-week low for StageZero Life Sciences Ltd?
What is StageZero Life Sciences Ltd stock price today?
What was StageZero Life Sciences Ltd stock price yesterday?
What is the 50-day moving average of StageZero Life Sciences Ltd?

Latest SZLS.TSX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.